Literature DB >> 22997768

[Contribution of the PCR assay to the diagnosis of Mansonella ozzardi in endemic areas of Argentina].

María F Degese1, Marta G Cabrera, Silvio J Krivokapich, Lucia E Irazu, Marcelo A Rodríguez, Eduardo A Guarnera.   

Abstract

Mansonella ozzardi is a tissue-dwelling parasitic nematode, the causative agent of mansonelliasis in almost all Latin American countries. It has been described along the Argentine Yungas region. The microscopic diagnosis can yield false-negative test results at low microfilaremia levels. The aim of this study was to optimize the molecular diagnostic technique and compare it with the Knott's method and standard blood smear procedures (thin blood films and thick smears) in 92 blood samples of individuals from an endemic area. The PCR technique followed by the sequencing of the amplified product yielded 100 % sensitivity compared to the Knott's test, which is considered a reference method. Seven more cases of this parasitosis could only be identified with the molecular technique.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22997768

Source DB:  PubMed          Journal:  Rev Argent Microbiol        ISSN: 0325-7541            Impact factor:   1.852


  3 in total

Review 1.  Mansonella ozzardi: a neglected New World filarial nematode.

Authors:  Nathália F Lima; Cecilia A Veggiani Aybar; María J Dantur Juri; Marcelo U Ferreira
Journal:  Pathog Glob Health       Date:  2016-05       Impact factor: 2.894

2.  In Silico Identification of Novel Biomarkers and Development of New Rapid Diagnostic Tests for the Filarial Parasites Mansonella perstans and Mansonella ozzardi.

Authors:  C B Poole; A Sinha; L Ettwiller; L Apone; K McKay; V Panchapakesa; N F Lima; M U Ferreira; S Wanji; C K S Carlow
Journal:  Sci Rep       Date:  2019-07-16       Impact factor: 4.379

3.  Mansonella ozzardi corneal lesions in the Amazon: a cross-sectional study.

Authors:  Lucas Monferrari Monteiro Vianna; Marilaine Martins; Marcos Jacob Cohen; Jacob Moyses Cohen; Rubens Belfort
Journal:  BMJ Open       Date:  2012-11-27       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.